RPL8

Large ribosomal subunit protein uL2 · P62917 · RPL8 on Sugi Atlas →

0 patent compounds predicted against RPL8, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL8 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors PHASE2RECRUITING
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates nanCOMPLETED
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq) nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) nanRECRUITING
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury nanCOMPLETED
Genetic Variants in Linear Localized Scleroderma nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
Advancing Neurogenetic Diagnoses Through Long-Read Sequencing nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a RPL8 binder may also engage these)

ProteinNameSimilarity
P62918 1.000 P62918 →
Q3T0S6 1.000 Q3T0S6 →
Q5R7Y8 1.000 Q5R7Y8 →
G1TT27 1.000 G1TT27 →
Q6PBF0 1.000 Q6PBF0 →
Q90YW1 1.000 Q90YW1 →
P62919 1.000 P62919 →
P0CX46 1.000 P0CX46 →
P0CX45 1.000 P0CX45 →
Q6P0V6 1.000 Q6P0V6 →
Q9V3G1 1.000 Q9V3G1 →
Q6FPN7 1.000 Q6FPN7 →
P41116 1.000 P41116 →
P41569 1.000 P41569 →
P0DJ52 1.000 P0DJ52 →
Q75AP7 1.000 Q75AP7 →
O15574 1.000 O15574 →
A0A1D8PF08 1.000 A0A1D8PF08 →
Q42064 1.000 Q42064 →
Q6RYS3 1.000 Q6RYS3 →
P13023 1.000 P13023 →
Q9U9L2 1.000 Q9U9L2 →
Q46G98 1.000 Q46G98 →
P46286 1.000 P46286 →
P25998 0.999 P25998 →
Q4PSL7 0.999 Q4PSL7 →
A9A141 0.999 A9A141 →
B1L707 0.999 B1L707 →
Q9XVF7 0.998 Q9XVF7 →
C3NEE6 0.998 C3NEE6 →